Broadx
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Broadx - overview
Established
2018
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Established in 2018 and based in Shenzhen, China, Broadx is a medical technology innovation company that focuses on research, development and production of automated molecular diagnostic products. The core team has more than ten years of experience in the IVD (In Vitro Diagnosis) industry. At present, the company has chip design and development, instrument research and development, and system testing laboratories in Shenzhen and Guangzhou. The company main business is research and development, production and sales of All-in-One and Sample in Result out integrated fully automated molecular diagnostic products.
The company plan to use the pre series A funding for accelerate the commercialization of multi-type nucleic acid detection systems.
Current Investors
Puhua Capital, Innovita Biological Technology Co., Ltd., Maccura Biotechnology Co.Ltd
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Diagnostic Equipment, Semiconductors
Website
www.broadx.com
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.